Home Illumina DNA test panel-based genotyping of whole genome amplified-DNA extracted from hair samples: performance and agreement with genotyping results from genomic DNA from buccal cells
Article
Licensed
Unlicensed Requires Authentication

Illumina DNA test panel-based genotyping of whole genome amplified-DNA extracted from hair samples: performance and agreement with genotyping results from genomic DNA from buccal cells

  • Ilir Agalliu , Peter A. Schweitzer , Suzanne M. Leanza , Robert D. Burk and Thomas E. Rohan
Published/Copyright: March 16, 2009

Abstract

Background: Hair is a DNA source that can be collected easily and inexpensively from participants in epidemiological studies. However, there is concern about DNA quality and quantity. Therefore, we assessed genotyping performance of whole genome amplified (WGA)-DNA extracted from hair using the GenomePlex® method and evaluated its agreement with genotyping results of buccal cell DNA from the same individuals, using the Illumina GoldenGate platform.

Methods: The Illumina DNA test panel includes 360 highly validated single nucleotide polymorphisms (SNPs) selected from the Linkage IV Panel that are distributed across the entire genome. DNA was extracted from both archived hair and buccal cell samples obtained from 44 randomly selected subjects participating in a large cohort study in Canada.

Results: The genotyping success rate was 97.7% for 44 paired samples. However, WGA-DNA from hair failed more during genotyping in comparison to buccal cell DNA. Hair samples with a pre-WGA-DNA ≥1 ng/μL quantified using the PicoGreen® assay (n=33) showed an average genotyping completion rate of 98.8% and SNP concordance of 91.2% with genotyping performance of buccal cell DNA. In contrast, samples with a pre-WGA-DNA <1 ng/μL had lower genotyping completion rate (94%) and poor SNP concordance (49%).

Conclusions: Results suggest that WGA-DNA obtained from hair can produce excellent genotyping call rates and show relatively good SNP concordance with results from buccal cell DNA using high-throughput technology. DNA quantity obtained from hair samples is a crucial determinant of genotyping performance. Larger studies are needed to examine the utility of hair DNA with different genotyping platforms.

Clin Chem Lab Med 2009;47:516–22.


Corresponding author: Ilir Agalliu, MD, ScD, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Ave., Belfer Bldg., Room 1315B, Bronx, NY 10461, USA Phone: +1-718-430-2929, Fax: +1-718-430-8780,

Received: 2008-11-13
Accepted: 2009-1-5
Published Online: 2009-03-16
Published in Print: 2009-05-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Review
  2. Pharmacogenetics of vitamin K antagonists: useful or hype?
  3. Genetics and Molecular Diagnostics
  4. Illumina DNA test panel-based genotyping of whole genome amplified-DNA extracted from hair samples: performance and agreement with genotyping results from genomic DNA from buccal cells
  5. Association of interleukin-18 gene promoter polymorphisms with risk of acute myocardial infarction in northern Chinese Han population
  6. MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis
  7. Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors
  8. Anti DNA antibodies are not restricted to a specific pattern of fluorescence on HEp2 cells
  9. General Clinical Chemistry and Laboratory Medicine
  10. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry
  11. Determination of urinary stone composition based on stone morphology: a prospective study of 325 consecutive patients in an emerging country
  12. Determination of branched chain amino acids, methionine, phenylalanine, tyrosine and α-keto acids in plasma and dried blood samples using HPLC with fluorescence detection
  13. Hematocytometry analysis as discriminative marker for asthma phenotypes
  14. A routine method for the quantification of the novel antimycotic drug posaconazole in plasma using liquid chromatography-tandem mass spectrometry
  15. Reference Values and Biological Variations
  16. Serum β2-microglobulin measured by immunonephelometry: expression patterns and reference intervals in healthy adults
  17. Serum enzyme profile characteristics of victims following the Wenchuan earthquake in China
  18. Stability of selected serum proteins after long-term storage in the Janus Serum Bank
  19. Spuriously high thyrotropin values due to anti-thyrotropin antibodies in adult patients
  20. Validation and Outcome Studies
  21. Workflow restrictions on hematology analyzers XE-2100 and XS-800 when assaying pediatric samples with limited volume
  22. Letters to the Editor
  23. Carbamylated hemoglobin remains a critical issue in HbA1c measurements
  24. Detection of a monoclonal gammopathy by serum index measurement
  25. Survey on the prevalence of hemolytic specimens in an academic hospital according to collection facility: opportunities for quality improvement
  26. Quantitative scanning analysis of a cryoglobulin ring detected in sera of patients with hepatitis C using a cooling gel diffusion method
  27. Significant reduction of erythrocyte glucose-6-phosphate dehydrogenase activity in soccer-players during play. Evidence for catecholamine mediated enzyme inhibition
Downloaded on 5.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.106/pdf
Scroll to top button